Samuel D. Colella - 24 Jun 2021 Form 4 Insider Report for Flexion Therapeutics Inc

Role
Director
Signature
/s/ Mark S. Levine, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
24 Jun 2021
Net transactions value
$0
Form type
4
Filing time
28 Jun 2021, 18:32:52 UTC
Next filing
19 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLXN Common Stock Award $0 +4,500 +67% $0.000000 11,198 24 Jun 2021 Direct F1, F2
holding FLXN Common Stock 1,000 24 Jun 2021 The Samuel Colella Trust F2
holding FLXN Common Stock 69,837 24 Jun 2021 By the Colella Family Trust F3
holding FLXN Common Stock 5,000 24 Jun 2021 By the Colella Family Exempt Marital Deduction Trust F4
holding FLXN Common Stock 994,129 24 Jun 2021 By Versant Venture Capital III L.P. F5
holding FLXN Common Stock 5,871 24 Jun 2021 By Versant Side Fund III F6
holding FLXN Common Stock 388,683 24 Jun 2021 By Versant Development Fund III, LLC F7
holding FLXN Common Stock 943 24 Jun 2021 By Colella Partners F8
holding FLXN Common Stock 19,653 24 Jun 2021 By Colella Partners II F9
holding FLXN Common Stock 250 24 Jun 2021 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLXN Stock option (right to buy) Award $0 +7,000 $0.000000 7,000 24 Jun 2021 Common Stock 7,000 $9.22 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan.
F2 Reflects the transfer of 1,000 shares to The Samuel Colella Trust.
F3 The shares are held by the Colella Family Trust UTA Dtd. 9/21/92 ("Colella Trust"). The Reporting Person is a trustee and beneficiary of the Colella Trust.
F4 The shares are held by the Colella Family Exempt Marital Deduction Trust Dated 9/21/1992 ("Colella Exempt Trust"). The Reporting Person is a trustee and beneficiary of the Colella Exempt Trust.
F5 The shares are held by Versant Venture Capital III, L.P. ("VVC III"). The Reporting Person is a managing member of Versant Ventures III, LLC ("VV III"), the sole general partner of VVC III and shares voting and dispositive power over the shares held by VVC III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein.
F6 The shares are held by Versant Side Fund III, L.P. ("Side Fund III"). The Reporting Person is a managing member of VV III, the sole general partner of Side Fund III and shares voting and dispositive power over the shares held by Side Fund III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein.
F7 The shares are held by Versant Development Fund III, LLC ("Development III"). The Reporting Person is a managing member of VV III, a majority member of Development III and shares voting and dispositive power over the shares held by Development III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein.
F8 Shares held by Colella Partners. The Reporting Person is the general partner of Colella Partners.
F9 Shares held by Colella Partners II. The Reporting Person is the general partner of Colella Partners II.
F10 The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant.